In this episode of The World of the API podcast, we have a chat with Teva Environmental, Social, Governance (ESG) experts, Itamar Schwartz and Adam Ajzensztejn about ESG in pharma. We talk about why ESG is such a buzz word at the moment, what impact the pharma industry can actually have, and what makes Teva's recent $5 billion sustainability-linked bond the first of its kind.
All content for The World of the API is the property of Teva api and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of The World of the API podcast, we have a chat with Teva Environmental, Social, Governance (ESG) experts, Itamar Schwartz and Adam Ajzensztejn about ESG in pharma. We talk about why ESG is such a buzz word at the moment, what impact the pharma industry can actually have, and what makes Teva's recent $5 billion sustainability-linked bond the first of its kind.
Respiratory APIs: A Peek into the Lab with Our Experts
The World of the API
17 minutes
4 years ago
Respiratory APIs: A Peek into the Lab with Our Experts
In this episode of The World of the API we deep-dive into the challenges of respiratory APIs. We join Dr. Ales Gavenda, Director of R&D in Czech Republic and Italy, and Oshrat Frankel, our Head of New Technologies, Innovation and Pre-formulation, for a guided tour.https://go.teva-api.com/l/293202/2022-01-10/w9xs57
The World of the API
In this episode of The World of the API podcast, we have a chat with Teva Environmental, Social, Governance (ESG) experts, Itamar Schwartz and Adam Ajzensztejn about ESG in pharma. We talk about why ESG is such a buzz word at the moment, what impact the pharma industry can actually have, and what makes Teva's recent $5 billion sustainability-linked bond the first of its kind.
